Great West Life Assurance CO Aptinyx Inc. Transaction History

Great West Life Assurance CO

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Jul 31, 2019	SELL	$2.95 - $4.38 $7,516 - $11,160	-2,548 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$16.15 - $28.93 $41,150 - $73,713	2,548 New	2,548 $40,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.